Message from President and Representative Director Takashi Matsuoka of chromocenter Inc.


We founded our company with a pledge to contribute to the support of disease treatment, drug development, and drug manufacturing, based on our own cutting-edge technologies, in order to deliver safe, reliable, and high-quality drugs to many people suffering from diseases as soon as possible. Since then, we have been working on the advancement of cell production technology, cell evaluation technology, vector technology, and multiple gene control technology, and our service are now widely used in the fields of biopharmaceuticals, regenerative medicine, and gene therapy. I would like to thank all of our stakeholders for their support.

On the other hand, looking at the world, common sense, perceptions, and social values that we used to take for granted are now being dramatically challenged. The way we work, production and logistics, cities and infrastructure, DX (Digital Transformation), geopolitical balance, the contradictory global economy, and the pressing environmental issues have all given birth to common global indicators such as the SDG’s (Sustainable Development Goals). The sense of impasse and crisis that we are experiencing one after another without pause for breath makes us feel the limits of the paradigm.

At a time when we are facing a crisis that cannot be solved by existing paradigms, we are proposing an “innovation platform” based on our own proprietary technologies that we have developed to contribute to a new paradigm shift through a scientific revolution.

All of us at the company will continue to make our best efforts to move forward into the future, keeping in mind the vow we made at the time of our founding. We look forward to working with you.

Takashi Matsuoka, President & Representative Director
chromocenter Inc.